Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Steven Prelack Insider Profile
4 Followers
Steven Prelack, Director at Galectin Therapeutics, holds 107.19K shares in Galectin Therapeutics (Ticker: GALT), holds ― shares in Pieris Pharmaceuticals (Ticker: PIRS), holds 24.48K shares in Aadi Bioscience (Ticker: AADI).
Steven Prelack has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Steven Prelack holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Apr 14, 2014 - Apr 14, 2015
Return:+69.50%
The most profitable trade made by Steven Prelack
Steven Prelack's Trading History
Galectin Therapeutics
Jul 08, 2015
Director
Uninformative Buy
―
$330.14K
Pieris Pharmaceuticals
―
Director
―
―
Aadi Bioscience
Jul 02, 2021
Director
Uninformative Buy
18.75K
$45.79K
List of latest transactions for each holding click on a transaction to see Steven Prelack's performance on stock
You May Also Like
Steven Prelack insider profile FAQ
What is the percentage of profitable transactions made by Steven Prelack?
The percentage of profitable transactions made by Steven Prelack is ―.
What is the average return per transaction made by Steven Prelack?
The average return per transaction made by Steven Prelack is ―.
What stocks does Steven Prelack hold?
Steven Prelack holds: GALT, PIRS, AADI stocks.
What was Steven Prelack’s latest transaction?
Steven Prelack latest transaction was an Uninformative Buy of ―.
What was Steven Prelack's most profitable transaction?
Steven Prelack’s most profitable transaction was an Informative Sell of GALT stock on April 14, 2014. The return on the trade was 69.50%.
What is Steven Prelack's role in Galectin Therapeutics?
Steven Prelack's role in Galectin Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.